A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase.

about

A study on the efficacy of the recombinant Yersinia adhesin A vaccine against yersiniosis in the early phase.

Item

http://www.wikidata.org/entity/Q40287170

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A study on the efficacy of the ...... ersiniosis in the early phase.

@en

type

Item

label

A study on the efficacy of the ...... ersiniosis in the early phase.

@en

prefLabel

A study on the efficacy of the ...... ersiniosis in the early phase.

@en

P1476

A study on the efficacy of the ...... ersiniosis in the early phase.

@en

P2093

Hiroko Yamanaka

http://www.w3.org/2001/XMLSchema#string

Kosuke Tsugo

http://www.w3.org/2001/XMLSchema#string

Shin-Ichi Nakamura

http://www.w3.org/2001/XMLSchema#string

Yumi Une

http://www.w3.org/2001/XMLSchema#string

P2860

The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll

Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains

Mycoplasma pneumoniae vaccine: antigenicity of buffered antigens in volunteers.

A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.

An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague

Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen)

A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis.

An outbreak of infection by Yersinia pseudotuberculosis in nonhuman primates.

Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.

P304

855-863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1292/JVMS.16-0528

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28320976

http://www.w3.org/2001/XMLSchema#string

P932

5447973

http://www.w3.org/2001/XMLSchema#string